http://www.staffoutsourcing.com offers affordable but high quality outsourcing options for a range of businesses from one man businesses looking to expand without taking on fixed costs to multi nationals who are looking for staff quickly or for short term projects. Visit the site for more information.
On July 21, 2014, Genworth (NYSE:GNW) is introducing Privileged Choice® Flex 3 featuring FlexFit℠ packages. FlexFit packages are designed to help address the primary barriers to purchasing long term care insurance – price and complexity. FlexFit gives millions more Americans the flexibility to choose the right fit for their long term care needs, combined with the simplicity of prepackaged benefits. Privileged Choice Flex 3 is issued by Genworth Life Insurance Company.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7206252-genworth-offers-affordable-flexfit-long-term-life-insurance/
Today, Genworth Financial, Inc (NYSE:GNW) announced the launch of its new website www.longtermcareinsurance.org, designed to help fill the information gap for consumers about the reality of long term care and the importance of planning for the future. The website, named the National Advisory Center for Long Term Care Information (NACLTCI), sponsored by Genworth, is focused on providing clear, concise and unbiased information to consumers faced with making decisions related to long term care.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7206251-genworth-launches-national-advisory-center-for-long-term-care-information-website/
In celebrating the 40th anniversary of hospice care in the United States, the National Hospice and Palliative Care Organization (NHPCO) is excited to introduce a new national campaign, “Moments of Life: Made Possible by Hospice,” that will show all Americans that hospice focuses on living and enables special moments and memories at the end of life for patients and loved ones.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7154751-national-hospice-and-palliative-care-organization-nhpco-campaign
Today, Novo Nordisk announced new phase 3 interim data from its guardianTM2 trial for its recombinant coagulation factor VIII (rFVIII) product NovoEight® (turoctocog alfa), the first new rFVIII molecule in over a decade, which shows that it provides long-term reduction from bleeding in people with haemophilia A when used as a preventative treatment.1 The results were presented at the World Federation of Haemophilia (WFH) World Congress and support findings from other studies within the guardianTM clinical programme that found NovoEight® demonstrated good efficacy in preventing and treating bleeds without inhibitor development in previously treated patients.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400529-novoeight-reduction-of-bleeding-haemophilia-a
Steelcase today released findings from its workplace research on how the physical environment can support or hinder mindfulness, along with five other dimensions of wellbeing. The researchers found that the physical environment offers behavioral cues, that can promote -- or hinder -- employee’s physical, cognitive and emotional states and long-term health.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7088951-steelcase-study-employee-focus-wellbeing-mindfulness-research
The cost of long term care continues rising at a rate outpacing inflation creating significant financial planning challenges for the nearly 12 million Americans currently in need of long term care services. According to the Genworth (NYSE: GNW) 2014 Cost of Care Survey released today, the cost of receiving in-home care continues to rise, though at a more moderate rate of growth. This is good news for consumers as almost three quarters of people needing long term care prefer receiving it in their homes, according to Genworth’s extensive claims data (Long term care claims Experience Data for Genworth Life Insurance Company and affiliates – December 1974-June 30, 2013).
To view the Multimedia News Release, go to http://www.multivu.com/mnr/70631511-genworth-2014-cost-of-care-survey-results
The G-Global info-communicative platform hosted an online conference on the 19th March on the theme “Draft Plan for overcoming long-term consequences of the global financial and economic crisis for UN Member States” in preparation for the second World Anti-Crisis Conference to be held in the Kazakhstan capital, Astana, on 21-23 May 2014. Mark Uzan, director of the Renovating Bretton Woods Committee, moderated the online-conference in which international and Kazakhstan experts participated. They reached agreement on a consolidated draft Plan for overcoming long-term consequences of the global financial and economic crisis for UN Member States (Plan) on which the international expert community has been actively working.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7140055-g-global-info-communicative-platform-draft-plan
This week Hill-Rom (NYSE: HRC) is featuring the Progressa® bed system, the next generation of intensive care unit (ICU) bed systems, at the American Organization of Nurse Executives (AONE) annual meeting in Orlando, Fla. The Progressa bed system is a therapeutic system designed to treat and prevent complications of immobility. It features a state-of-the-art design that supports treatment goals and was engineered to help address patient migration via its StayInPlace™ technology.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/66137-hill-rom-new-progressa-bed-system
Hilary Duff, new mother to 22-month-old son Luca, is volunteering her time to help the March of Dimes raise funds to help give more babies a healthy start in life.
”As a mom, I'm proud to support the March of Dimes helping more women have full term pregnancies and healthy babies. That’s why I walk in March for Babies,” she says in a new public service advertisement. “The money we raise funds research and local programs that help babies overcome the challenges of premature birth and birth defects. Together we can help make healthier babies possible for thousands of families.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/65164-march-of-dimes-march-for-babies-2014/
The Alfred Mann Foundation (AMF) today announced the first subject, a U.S. Marine, SSgt James Sides, as a recipient of its highly anticipated IMES System (implantable myoelectric sensor) – an experimental system that holds the promise of being the first minimally invasive, intuitive, multi-channel control system for prosthetics intended for long term use. The IMES System is currently being studied under the Investigational Device Exemption (IDE) regulations of the U.S. Food and Drug Administration (FDA). AMF’s ongoing trial with injured veterans at the Walter Reed National Medical Military Center anticipates subjects intuitively operating three different prosthetic movements simultaneously: opening and closing the hand, rotating the wrist, and moving the thumb. Combining these three movements enables several grasps that are invaluable for performing everyday tasks.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65112-alfred-mann-foundation-u-s-marine-subject-fda-study-for-imes-system
The first comprehensive long-term study comparing different medications for type 2 diabetes is launching nationwide. The GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Study will compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64578-grade-glycemia-reduction-approaches-in-diabetes-comparative-effectiveness